ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Scrip's Five Must-Know Things - 1 April 2024"
Episode Synopsis
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.
https://scrip.citeline.com/SC150030/Quick-Listen-Scrips-Five-MustKnow-Things
https://scrip.citeline.com/SC150030/Quick-Listen-Scrips-Five-MustKnow-Things
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
In God we trust